Family Medicine · Holton, KS
NPI
1952371163
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1603 W 4th St
Holton, KS, 66436
Phone (785) 364-3205
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,625
209 services
Medicare patients, 2024
66
Average age 80
Drug cost, 2024
$667K
8,823 prescriptions
Company payments, 2025
$641
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Allen was code 99238 (hospital discharge management), 49 times for 38 patients. In total David R Allen billed 209 services in 16 codes, and Medicare paid $9,625.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99238 Hospital Discharge Management | Facility | 49 | 38 | $56.86 | $2,786 |
| 99231 Hospital E&M - Subsequent | Facility | 45 | 24 | $34.50 | $1,552 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 25 | $53.73 | $2,257 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 26 | 22 | $35.88 | $933 |
By year: 2022 $4,387 for 108 services; 2023 $8,981 for 173 services; 2024 $9,625 for 209 services.
Medicare prescription drug claims, 2024
In 2024, the drug David R Allen prescribed most often to Medicare patients was Levothyroxine Sodium, with 383 prescriptions and refills. In total David R Allen wrote 8,823 Medicare prescriptions that cost $667K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 383 | 752 | 77 | $2,551 |
| Tamsulosin Hcl Generic | 355 | 662 | 73 | $5,426 |
| Potassium Chloride Generic | 265 | 416 | 58 | $3,500 |
| Amlodipine Besylate Generic | 255 | 510 | 56 | $1,590 |
| Gabapentin Generic | 236 | 330 | 49 | $4,381 |
| Atorvastatin Calcium Generic | 236 | 572 | 68 | $2,893 |
| Furosemide Generic | 230 | 343 | 48 | $765 |
| Omeprazole Generic | 229 | 433 | 45 | $2,650 |
| Lisinopril Generic | 224 | 509 | 51 | $1,751 |
| Rosuvastatin Calcium Generic | 219 | 472 | 62 | $2,117 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 214 | 214 | 37 | $2,443 |
| Metformin Hcl Generic | 190 | 412 | 43 | $838 |
| Pantoprazole Sodium Generic | 166 | 315 | 44 | $2,155 |
| Losartan Potassium Generic | 147 | 381 | 39 | $1,375 |
| Tramadol Hcl Generic | 135 | 135 | 32 | $1,076 |
Brand drugs: 1,247 claims; generic drugs: 7,540 claims; opioid claims: 531.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Allen $641 ($641 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $171.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $59.61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $58.93 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $47.57 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $44.95 |
| Ascensia Diabetes Care Us Inc. | 2 | $33.88 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $30.43 |
| Novo Nordisk Inc NVO | 2 | $29.1 |
| Amgen Inc. AMGN | 2 | $29.03 |
| Verona Pharma, Inc. VRNA | 2 | $27.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.